Abstract
The in situ response of clonogenic cells in murine intestinal crypts to graded doses of 12 clinically used cytotoxic drugs has been measured by the crypt microcolony assay. For the alkylating agents mechlorethamine hydrochloride and BCNU, survival curves down to three logs of crypt depletion could be obtained. However, with isopropyl methane sulphonate only one log of depletion was measurable, and for a fourth alkylating agent, cyclophosphamide, no crypt killing occurred before other toxicities resulted in death of the animal in less than 3-4 days. This is the major constraint on the use of the microcolony assay with cytotoxic drugs. Of four antibiotics, survival curves were obtainable for adriamycin, bleomycin and mitomycin C, but not for actinomycin D. 5-Fluorouracil gave only a limited degree of crypt kill. Of three S-phase-specific drugs, hydroxyurea and vincristine resulted in little or no crypt depletion, but there was dose-dependent crypt depletion after methotrexate. The complexities of applying cellular-kinetic classifications of cytotoxic drugs to in situ endpoints are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.